Quick Answer
NEUROCRINE BIOSCIENCES INC reported Revenue From Contract With Customer Excluding Assessed Tax of $2.86 billion for the year ending 2025.
- NEUROCRINE BIOSCIENCES INC showed an increase of +21.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), NEUROCRINE BIOSCIENCES INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 18,970.0%.
- Historical annual values: Fiscal year 2025: $2.86 billion | Fiscal year 2024: $2.36 billion | Fiscal year 2023: $1.89 billion | Fiscal year 2022: $1.49 billion | Fiscal year 2021: $1.13 billion | Fiscal year 2020: $1.05 billion | Fiscal year 2019: $788.10 million | Fiscal year 2018: $451.20 million | Fiscal year 2017: $161.63 million | Fiscal year 2016: $15.00 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: